Davide Semilia
The Blizzard of Uncertainty: Tariffs and Trial Failures Cold-Snap Wall Street 📖 MARKET BRIEFING - 24/02/2026 A 15-inch blizzard has buried Manhattan, but the real frost is creeping into global trade corridors. As New York braces for a whiteout, investors face a more systemic chill: a defiant 15% tariff rate from Washington and a multi-billion dollar weight-loss dream turning into a clinical nightmare. The three acts of today: THE TARIFF DEFIANCE Despite a Supreme Court setback, the administration is doubling down on a 15% global tariff rate. The EU has reacted by freezing its trade deal ratification, while the dollar recouped losses as traders hedge against a full-scale trade war. JPM warns we have reached a "plateau of uncertainty" that is stifling global capital. THE GLP-1 SHOCKWAVE Novo Nordisk shares plummeted 15% today, wiping out massive market value after its next-gen weight-loss pill failed to outpace Eli Lilly in clinical trials. This stumble proves that in the "miracle drug" race, the price of second place is absolute, causing a ripple effect across the entire European healthcare sector. THE LIQUIDITY DUMP Hedge funds are offloading global equities at the fastest pace since April 2025. Bitcoin ETFs have suffered a historic $3.8 billion outflow over five weeks, highlighting a massive institutional retreat. Even Michael Saylor’s 100th purchase of $39.8 million in BTC couldn't stop the "extreme fear" sentiment from returning to the crypto space. THE PLOT TWIST While the world obsesses over AI's "debt binge," Morgan Stanley is quietly rotating into "AI-proof" emerging market assets, betting that the massive hyperscaler capex is nearing a breaking point that will soon shatter the "unspoken contract" with tech investors. WHAT IT MEANS FOR US Tactical caution is mandatory as trade tensions escalate. We are looking at defensive havens like the Swiss Franc, which Morgan Stanley analysts suggest could surge 17% as the US trade policy remains in a state of flux. 📖 Will today's NVIDIA earnings thaw the market's growing fear, or is the AI winter finally arriving? $NVO (Novo-Nordisk A/S SPONS ADR) $LLY (Eli Lilly & Co) $BTC $NVDA (NVIDIA Corporation) $USDCHF
Not investment advice. The author may have financial interests in the mentioned instruments.
null
.